Emma Koehn

Australians living with MS face an anxious wait to find out whether medications integral to their daily functioning will remain on the PBS for the long term.

Health systems are struggling to work out when the price is right for personalised cancer treatments, hampering patient access, Australian researchers have found.

Intermittent fasting has attracted plenty of attention over the past decade, and now a group of US endocrinologists and nutrition experts say the

The number of Australian patients receiving incident SGLT2i monotherapy increased by 82% per year from 2020, while monotherapy with GLP-1RAs jumped by 73% a year from 2014, according to analysis of PBS data.

A Sydney bariatric surgeon has been vindicated after a patient claimed a biliopancreatic diversion procedure completed more than two decades ago left him with serious physical and psychiatric injuries.

We're in the middle of the obesity drug revolution, but a major review of hundreds of clinical trials has put a serious question mark over whether

The American Heart Association has outlined the four types of patients who may benefit from deprescribing of medications for cardiovascular

The Medical Services Advisory is running the ruler over an application to fund NT-proBNP testing under Medicare to help guide the treatment of patients with heart failure.

A panel of 45 US specialists has agreed on which cutaneous squamous cell carcinomas need staging and surveillance imaging, citing bone invasion and tumours larger than 4cm as key risk features.

Dr Farrah Rodrigues There are calls to simplify lipid screening guidelines for young patients with type 1 diabetes, after a Melbourne study